About the ABPI

About the ABPI

ABPI Manifesto for Investment, Health and Growth

Read the ABPI Manifesto for Investment, Health and Growth
ABPI Manifesto for Investment, Health and Growth

Who we are

The ABPI exists to make the UK the best place in the world to research, develop and access medicines and vaccines to improve patient care.

We represent companies of all sizes which invest in making and discovering medicines and vaccines to enhance and save the lives of millions of people around the world.

Our members and affiliates include established research-based pharmaceutical companies, specialist service providers that support pharmaceutical R&D, and organisations that work and interact with the pharmaceutical industry in the UK.

We work in partnership with the government, regulators, and the NHS, enabling patients to access new and effective treatments and vaccines more quickly.

We collaborate with our partners across the life sciences ecosystem to make the UK an attractive location to invest and scale.

What we do

We work to improve access to new medicines and vaccines so everyone in the UK can access the latest treatments.

We work to build a thriving UK environment to research, develop, and manufacture new medicines and vaccines.

We work to enhance the reputation of our industry by setting the highest ethical standards and communicating the benefits our members bring to patients, the NHS and the UK economy.

We work to ensure the UK continues to play a positive role on the global stage defending intellectual property and supporting cooperation on research and international issues.

We work to enhance how health data can transform medicines development and improve patient care.

We work with our members to champion industry, NHS and patient organisation partnerships.

Our strategy

Medicines and vaccines are transforming our lives like never before. We want the UK to be the best place in the world to research, develop and use the medicines and vaccines of the future. 

Our strategy

To do this, we focus on:

  • Improving access to new medicines and vaccines so everyone in the UK can get the latest treatments.

  • Building a thriving environment for medicine discovery so the UK can be the best place in the world to research and develop new medicines and vaccines.

  • Enhancing reputation by demonstrating the high ethical standards we set ourselves and that society expects from us.

  • Working in partnership with Government, the NHS and the life science community

  • Providing UK leadership to drive global medicines policy.

  • Improving how health data can transform medicine 
development and improve patient care.

  • Representing our members, using their insight and 
experience to tell the story of how they change the
lives of millions of people every day.

The ABPI’s Equality, Diversity and Inclusion Strategy

Creating diverse and inclusive workplaces that deliver innovations to improve the lives of everyone in the UK is critical if we are to deliver on our mission.

ABPI ED&I Policy 871X581

ABPI Group

Prescription Medicines Code of Practice Authority (PMCPA)

The Prescription Medicines Code of Practice Authority (PMCPA) was established by The Association of the British Pharmaceutical Industry to operate the ABPI Code of Practice for the Pharmaceutical Industry independently of the ABPI.

The PMCPA is a division of the ABPI which is a company limited by guarantee registered in England & Wales no 09826787 and its registered office is at 2nd Floor Goldings House, Hay’s Galleria, 2 Hay’s Lane, London, SE1 2HB.

Office of Health Economics (OHE)

The purpose of the Office of Health Economics (OHE) is to advance the education of the public in general/health care payers/policy makers (and particularly patients and healthcare professionals) on the subject of health economics and healthcare policy.

The OHE is a company limited by guarantee registered in England and Wales (registered number 09848965) and its registered office is at 2nd Floor Goldings House, Hay’s Galleria, 2 Hay’s Lane, London, SE1 2HB.